Direxion Daily S&P Biotech Bear 1X ETF (LABS) Analysis
Bu sayfa İngilizce aslından yapay zekâ ile çevrildi; İngilizce sürüm esastır. İngilizce sürümü oku
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir.
Direxion Daily S&P Biotech Bear 1X ETF (LABS) ETF — Price, Holdings & Analysis
ETF Genel Bakış
Risk Metrikleri
- Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) — 0.59% expense ratio
- State Street Energy Select Sector SPDR ETF (XLE) — 0.08% expense ratio
- WisdomTree Emerging Markets ESG Fund (DVEM) — 0.32% expense ratio
- State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) — 0.16% expense ratio
- Invesco QQQ Trust, Series 1 (QQQ) — 0.18% expense ratio
- iShares FinTech Active ETF (BPAY) — 0.66% expense ratio
- State Street Technology Select Sector SPDR ETF (XLK) — 0.08% expense ratio
- ARK Innovation ETF (ARKK) — 0.75% expense ratio
- Direxion Daily Industrials Bull 3X ETF (DUSL) (Equity) — 0.98% expense ratio
- Direxion Daily Global Clean Energy Bull 2X Shares (KLNE) (Equity) — 1.33% expense ratio
- Direxion Daily XOM Bull 2X ETF (XOMX) (Equity) — 2.36% expense ratio
- Direxion MSCI Developed Over Emerging Markets ETF (RWDE) (Equity) — 0.53% expense ratio
- Direxion Daily Uranium Industry Bull 2X ETF (URAA) (Equity) — 1.46% expense ratio
- Direxion World Without Waste ETF (WWOW) (Equity) — 0.50% expense ratio
Sorular & Cevaplar
How long has LABS been around?
Direxion Daily S&P Biotech Bear 1X ETF was launched in 2015, making it 11 years old. With over a decade of history, it has navigated various market conditions.
Is LABS a good investment?
Direxion Daily S&P Biotech Bear 1X ETF is a equity ETF. Equity ETFs are subject to market risk and can experience significant short-term volatility, though they have historically provided strong long-term returns for patient investors.
Whether it is suitable depends on your investment goals, risk tolerance, and time horizon. Consider consulting a financial advisor for personalized guidance.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
Bu sayfayı makine yazdı, sayfa sayfa insan denetiminden geçmedi. Editoryal denetim sistemiktir: kurallar ve kaynaklar denetlenir, tek tek sayfalar denetlenmez.